About Us

Founded in 2014, Exactis Innovation (Exactis) is a Business-Led Networks Centres of Excellence (BL-NCE) that comprises a pan-Canadian Network of 14 oncology centers that brings together public and private partners focusing on precision oncology research.

Our Approach to Precision Oncology

exactis animation, Personalize my Treatment (PMT)

What We Do

Personalize my Treatment (PMT) is an active pan-Canadian longitudinal cancer patient registry comprised of clinical and molecular data.

Exactis’ Clinical & Translational Operations team has proven experience in developing and managing longitudinal biomarker-based clinical trials and translational research.

Through our 14 site Network and PMT registry, our program for real-world effectiveness in precision oncology enables the assessment of cancer sub-populations in the real-world setting.

Ethical Commitment

Exactis is committed to conducting its activities with the highest ethical and professional standards to ensure respectful treatment of patients and all stakeholders, this includes respecting the rights and privacy of patients, ethical standards and regulatory requirements.

Vision & Mission

Our Vision: “Exactis aims to improve cancer survivorship through innovative care”.


Our Mission: “To accelerate precision oncology by integrating molecular and clinical patient profiles into innovative clinical and translational projects”

Investigators’ Insights/Experience

  • We have been working with Exactis over the last two years to launch and support our multicenter pediatric study. The Exactis Team provides invaluable support for regulatory matters, monitoring and data management. They are always available, efficient and dedicated. There is no doubt we will continue our collaboration with Exactis for our upcoming studies.

    Dr. Sébastien Perreault M.D, FRCPC
    Clinicien-chercheur, Neurologie pédiatrique, Neuro-oncologie UCNS, CHU Sainte-Justine